BioSpace News Archive

Onxeo S.A. announced the presentation of preclinical data supporting the differentiated ability of AsiDNA™, its first-in-class DNA Damage Response inhibitor, to reverse resistance to PARP inhibitors by preventing death-tolerant cells regrowth.

Avero Diagnostics, a physician-owned laboratory, is now providing molecular testing for COVID-19.

Cigna and MultiCare Health System have reached a multi-year agreement that ensures access to quality care for Cigna customers at predictable, affordable rates.

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for unmet medical need, announces its results for the first quarter 2020.

Researchers from Moorfields Eye Hospital, Homerton NHS Trust, and University College London find EyeArt System to have 100% sensitivity in detecting vision-threatening retinopathy

VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), today announced the filing of a key Patent Cooperatio

Medela LLC, announced the opening of a new manufacturing line in the U.S. for its Vario 18 AC Portable Suction Pumps, that provide crucial suction and fluid removal during respiratory treatment provided by ventilators.

Altogen Labs, a GLP-compliant contract research laboratory (CRO), offers in vivo xenograft efficacy studies and pharmacology/toxicology services designed to accelerate preclinical research and drug development. Cancer pathologies without a therapeutic solution have unfortunately not disappeared in the context of the global COVID-19 crisis. Altogen Labs rem

Erhardt was previously Senior Vice President, Head of Clinical Development & Operations at Pfizer --